CTSO
Cytosorbents Corporation
NASDAQ · Healthcare · Medical - Devices · US
$0.35
+0.03%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 12.21x
- P/S forward
- 0.52x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -29.30x
- Price / sales
- 0.59x
- Price / cash flow
- -2.13x
Enterprise value
- Enterprise value
- $43.9M
- EV / sales
- 1.18x
- EV / EBITDA
- -3.11x
- EV / EBIT
- -3.54x
- Market cap
- $22.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026